Life Science Washington Venture Investment & Partnering Forum With Bristol Myers Squibb
Seattle, WA 98102
Event summary
Cooley is pleased to sponsor the Venture Investment & Partnering Forum With Bristol Myers Squibb (BMS), which brought investors and strategic partners to Seattle for a showcase of the most promising life sciences companies and research opportunities in Washington. BMS partners with companies offering innovative technologies, products and therapies that accelerate growth and advance patient care. BMS met with companies and researchers in specific focus areas – including solid tumor oncology, immuno-oncology, cell therapy, and manufacturing, cell and gene technologies – to discuss potential collaborations, partnerships, investment, licensing opportunities and M&A.
Schedule and locations
- Monday, February 13, 2023: Plenary session and networking reception, 4:00 – 6:00 pm PST at Life Science Washington
- Tuesday, February 14, 2023: Pre-scheduled one-on-one meetings with Bristol Myers Squibb at Cooley’s Seattle office
For more information, please email Brendon Fei.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.